Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jan;116(1):3-12.
doi: 10.1111/vox.12996. Epub 2020 Sep 28.

In vitro diagnostics for screening the blood supply: the new European regulation for IVD and the WHO IVD prequalification programme

Herbert Afegenwi Mbunkah  1 , Jens Reinhardt  2 , Chancelar Kafere  1 , Heiner Scheiblauer  3 , Irena Prat  4 , Claudius Micha Nübling  1
Affiliations
Review

In vitro diagnostics for screening the blood supply: the new European regulation for IVD and the WHO IVD prequalification programme

Herbert Afegenwi Mbunkah et al. Vox Sang. 2021 Jan.

Abstract

Blood transfusion remains a routine life-saving medical procedure that helps replace blood lost due to surgery, injury or disease. The quality of transfused blood is crucial in this process as blood donors must be free of transfusion-transmissible infections and donated blood should be compatible to that of the recipient. The quality of donated blood could be affected by the quality of in vitro diagnostic medical devices (IVDs) used in the screening process. Consequently, the need for high-quality, safe and well-performing IVDs for use in transfusion medicine arises, accompanied by the need for tight regulations in this domain. In the European Union, the new IVD Regulation will replace the existing IVD Directive within a five-year transitional period. Manufacturers of IVDs are expected to fully comply with the new Regulation by 26 May 2022. In this review, we address the major differences relating to marketing authorization and testing between this new Regulation and its predecessor. We further present the main elements of the prequalification assessment introduced by the WHO for IVDs, including disease-specific IVDs for blood screening laboratories.

Keywords: IVD regulation; TTIs; blood transfusion; prequalification.

PubMed Disclaimer

References

    1. Global Harmonization Task Force: Definition of the Terms ‘Medical Device’ and ‘In Vitro Diagnostic (IVD) Medical Device’, 2012. http://www.imdrf.org/docs/ghtf/final/sg1/technical-docs/ghtf-sg1-n071-20.... [Last Accessed 30 June 2020]
    1. Bönig H, Schmidt M, Hourfar K, et al.: Sufficient blood, safe blood: can we have both? BMC Med 2012; 10:29
    1. World Health Organization: Screening donated blood for transfusion-transmissible infections, 2010. https://www.who.int/bloodsafety/ScreeningTTI.pdf. [Last Accessed 30 June 2020]
    1. Candotti D, Assennato SM, Laperche S, et al.: Multiple HBV transfusion transmissions from undetected occult infections: revising the minimal infectious dose. Gut 2019; 68:313-321
    1. European Commission: Factsheet for Manufacturers of in vitro Diagnostic Medical Devices, 2018. https://ec.europa.eu/growth/sectors/medical-devices_en. [Last Accessed 30 June 2020]

LinkOut - more resources